Hormone therapy and breast cancer

Area of Science:

• Reproductive Health
• Oncology
• Public Health

Background:

• Hormone therapy (HT) use is a significant decision for menopausal women.
• HT offers benefits like osteoporosis prevention but carries potential breast cancer risks.
• Family history of breast cancer may influence attitudes toward HT, but this is understudied.

Purpose of the Study:

• To investigate differences in attitudes toward hormone therapy (HT) among menopausal women based on their family history of breast cancer.
• To explore how a family history of breast cancer impacts women's perceptions and decisions regarding HT.

Main Methods:

• A cross-sectional study was conducted with 110 menopausal women in rural Pennsylvania.
• Participants completed a Health Belief Model attitudinal scale.
• Women were divided into two groups: those with and without a family history of breast cancer.

Main Results:

• No significant differences were found in overall attitudes toward HT between the two groups.
• However, women with a family history of breast cancer reported a significantly higher frequency of fear related to breast cancer when considering HT (P = .04).

Conclusions:

• While overall attitudes toward HT may not differ, fear of breast cancer is a significant factor for women with a family history.
• Further research is needed on women's attitudes toward HT and its impact on postmenopausal healthcare management.
• Personalized counseling on HT risks and benefits, considering family history, is crucial for informed decision-making.